|
Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
|---|---|
| Apr 25, 2018 |
print number 1531a |
| Apr 25, 2018 |
amend and recommit to health |
| Jan 03, 2018 |
referred to health |
| Jan 12, 2017 |
referred to health |
Assembly Bill A1531A
2017-2018 Legislative Session
Sponsored By
BRAUNSTEIN
Archive: Last Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Bill Amendments
co-Sponsors
Jeffrey Dinowitz
Steven Otis
Anthony Brindisi
multi-Sponsors
David McDonough
2017-A1531 - Details
2017-A1531 - Bill Text download pdf
S T A T E O F N E W Y O R K
________________________________________________________________________
1531
2017-2018 Regular Sessions
I N A S S E M B L Y
January 12, 2017
___________
Introduced by M. of A. BRAUNSTEIN, DINOWITZ, OTIS, BRINDISI -- Multi-
Sponsored by -- M. of A. McDONOUGH, McLAUGHLIN -- read once and
referred to the Committee on Health
AN ACT to amend the public health law, in relation to prescribing an
opioid antagonist with a patient's first opioid analgesic prescription
in a given year
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Section 3302 of the public health law is amended by adding
two new subdivisions 44 and 45 to read as follows:
44. "OPIOID ANALGESICS" MEANS THE MEDICINES BUPRENOPHINE, BUTORPHANOL,
CODEINE, HYDROCODONE, HYDROMORPHONE, LEVORPHANOL, MEPERIDINE, METHADONE,
MORPHINE, NALBUPHINE, OXYCODONE, OXYMORPHONE, PENTAZOCINE, PROPOXYPHENE
AS WELL AS THEIR BRAND NAMES, ISOMERS AND COMBINATIONS.
45. "OPIOID ANTAGONIST" MEANS AN FDA-APPROVED DRUG THAT, WHEN ADMINIS-
TERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL
EFFECTS OF AN OPIOID IN THE BODY. THE OPIOID ANTAGONIST IS LIMITED TO
NALOXONE OR OTHER MEDICATIONS APPROVED BY THE DEPARTMENT FOR THIS
PURPOSE.
§ 2. Section 3309 of the public health law is amended by adding a new
subdivision 7 to read as follows:
7. EVERY INITIAL OPIOID ANALGESIC PRESCRIPTION PER YEAR SHALL BE
ACCOMPANIED WITH A PRESCRIPTION FOR AN OPIOID ANTAGONIST.
§ 3. This act shall take effect on the ninetieth day after it shall
have become a law; provided, however, that effective immediately, the
addition, amendment and/or repeal of any rule or regulation necessary
for the implementation of this act on its effective date are authorized
to be made and completed by the commissioner of health on or before such
effective date.
EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD01695-01-7
co-Sponsors
Jeffrey Dinowitz
Steven Otis
Anthony Brindisi
John T. McDonald III
multi-Sponsors
David McDonough
2017-A1531A (ACTIVE) - Details
2017-A1531A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K
________________________________________________________________________
1531--A
2017-2018 Regular Sessions
I N A S S E M B L Y
January 12, 2017
___________
Introduced by M. of A. BRAUNSTEIN, DINOWITZ, OTIS, BRINDISI -- Multi-
Sponsored by -- M. of A. McDONOUGH -- read once and referred to the
Committee on Health -- recommitted to the Committee on Health in
accordance with Assembly Rule 3, sec. 2 -- committee discharged, bill
amended, ordered reprinted as amended and recommitted to said commit-
tee
AN ACT to amend the public health law, in relation to prescribing an
opioid antagonist with a patient's first opioid analgesic prescription
in a given year
THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:
Section 1. Section 3302 of the public health law is amended by adding
two new subdivisions 44 and 45 to read as follows:
44. "OPIOID ANALGESICS" MEANS THE MEDICINES BUPRENOPHINE, BUTORPHANOL,
CODEINE, HYDROCODONE, HYDROMORPHONE, LEVORPHANOL, MEPERIDINE, METHADONE,
MORPHINE, NALBUPHINE, OXYCODONE, OXYMORPHONE, PENTAZOCINE, PROPOXYPHENE
AS WELL AS THEIR BRAND NAMES, ISOMERS AND COMBINATIONS.
45. "OPIOID ANTAGONIST" MEANS AN FDA-APPROVED DRUG THAT, WHEN ADMINIS-
TERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN PART THE PHARMACOLOGICAL
EFFECTS OF AN OPIOID IN THE BODY. THE OPIOID ANTAGONIST IS LIMITED TO
NALOXONE OR OTHER MEDICATIONS APPROVED BY THE DEPARTMENT FOR THIS
PURPOSE.
§ 2. Section 3309 of the public health law is amended by adding a new
subdivision 7 to read as follows:
7. EVERY INITIAL OPIOID ANALGESIC PRESCRIPTION PER YEAR, WHICH IS
EQUAL TO OR GREATER THAN FIFTY MORPHINE MILLIGRAM EQUIVALENTS, SHALL BE
ACCOMPANIED WITH A PRESCRIPTION FOR AN OPIOID ANTAGONIST.
§ 3. This act shall take effect on the ninetieth day after it shall
have become a law; provided, however, that effective immediately, the
addition, amendment and/or repeal of any rule or regulation necessary
for the implementation of this act on its effective date are authorized
to be made and completed by the commissioner of health on or before such
effective date.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.